<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Date: 2015-02-25 06:08:47Iron metabolism Iron deficiency anemia Iron deficiency Iron supplements Human iron metabolism Anemia Total iron-binding capacity Iron Hepcidin Medicine Chemistry Biology |
| THE METABOLISM OF IRON IRON IO IONS Oral supply 5-25% availabilityDocID: 1ptV5 - View Document |
| Turning Spiegelmers into Drugs NOXXON Pharma is a biopharmaceutical company pioneering the development of a new class of proprietary therapeutics called Spiegelmers*, the chemically synthesized, immunologically passive aDocID: 1a5Tb - View Document |
| PRESS RELEASE First Data from NOXXON’s NOX-H94 (Lexaptepid Pegol) Clinical Trial in ESA-Hyporesponsive Dialysis Patients Reported at ERA-EDTA Conference Berlin, Germany and Boston, USA - May 29, NOXXON Pharma aDocID: 19ryN - View Document |
| PDF DocumentDocID: 191Vu - View Document |
| LEAD Action News vol 9 no 3 Short Part 1DocID: 183Zb - View Document |